The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2026 | Opportunities and limitations of AI-driven incidental pulmonary nodule detection
Luis Raez, MD, FACP, FASCO, Memorial Cancer Institute, Pembroke Pines, FL, explores opportunities and limitations of incidental pulmonary nodule detection using artificial intelligence (AI). The program relied on stored lung scan records, which were not applicable to all patients, however the use of AI allowed for a large number of scans to be reviewed. This interview took place at the IASLC 2026 World Conference on Lung Cancer congress in Seoul, Republic of Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
